Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04399694 · ClinicalTrials.gov registry record
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 56
- Enrollment target
NCT04399694 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 56 participants.
The verdict
NCT04399694 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
The goal of this study is to identify and characterize novel non-coding and splicing variants that may contribute to genetic disorders. We will particularly focus on patients with a diagnosed genetic disorder that has inconclusive genetic findings.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2020-03-03 |
| Est. Completion | 2024-04-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04399694
The ClinicalTrials.gov registry entry for NCT04399694 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04399694 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04399694 about?
NCT04399694 is a clinical study titled "Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders". The goal of this study is to identify and characterize novel non-coding and splicing variants that may contribute to genetic disorders. We will particularly focus on patients with a diagnosed genetic disorder that has inconclusive genetic findings.
What is the current status of trial NCT04399694?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2020-03-03. Estimated completion is 2024-04-11.
Who is sponsoring clinical trial NCT04399694?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.